MENU
+Compare
GENPF
Stock ticker: OTC
AS OF
Jun 6 closing price
Price
$0.01
Change
-$0.03 (-75.00%)
Capitalization
2.68M

GENPF GENIX PHARMACEUTICALS CORP. Forecast, Technical & Fundamental Analysis

Genix Pharmaceuticals Corp is a Canadian life sciences company focused on the research, development, manufacturing, sales, and distribution of novel, branded generic ophthalmic drugs, and ophthalmic OTC products... Show more

GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for GENPF with price predictions
Jul 03, 2025

Momentum Indicator for GENPF turns positive, indicating new upward trend

GENPF saw its Momentum Indicator move above the 0 level on June 23, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 27 similar instances where the indicator turned positive. In of the 27 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GENPF just turned positive on June 27, 2025. Looking at past instances where GENPF's MACD turned positive, the stock continued to rise in of 19 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

GENPF moved below its 50-day moving average on June 06, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GENPF crossed bearishly below the 50-day moving average on June 06, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.302) is normal, around the industry mean (62.462). P/E Ratio (0.000) is within average values for comparable stocks, (88.783). GENPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. GENPF's P/S Ratio (370.370) is very high in comparison to the industry average of (19.280).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GENPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GENPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
GENPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
1055 West Hastings Street
Phone
+1 604 609-6198
Employees
N/A
Web
https://www.genixpharm.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PWR386.5113.10
+3.51%
Quanta Services
LQDA12.190.13
+1.08%
Liquidia Corp
RGTI13.08N/A
N/A
Rigetti Computing
HXL57.30-0.24
-0.42%
Hexcel Corp
SWAG1.43-0.02
-1.38%
Stran & Company

GENPF and Stocks

Correlation & Price change

A.I.dvisor tells us that GENPF and ARSUF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GENPF and ARSUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GENPF
1D Price
Change %
GENPF100%
N/A
ARSUF - GENPF
23%
Poorly correlated
N/A
IMCC - GENPF
12%
Poorly correlated
+12.12%
VPHIF - GENPF
2%
Poorly correlated
N/A
CLCFF - GENPF
2%
Poorly correlated
N/A
AYRWF - GENPF
1%
Poorly correlated
-4.96%
More